{"schema_version":"secwatch.filing_event.v1","accession":"0001663577-23-000139","form_type":"8-K","ticker":"MDNC","cik":"0001931055","company_name":"Medinotec Inc.","filed_at":"2023-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.460527+00:00","generated_at":"2026-06-17T08:34:33.111613+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Medinotec Inc. approved to trade on OTCQX Best Market under symbol MDNC","bullets":["OTC Markets notified Medinotec on March 30, 2023; trading on OTCQX began March 31, 2023.","Company qualifies for OTCQX by meeting high financial standards and corporate governance requirements.","B. Riley Securities acted as OTCQX sponsor for the upgrade.","CEO Gregory Vizirgianakis cited increased exposure and commitment to shareholder value.","Medinotec plans to expand US sales, initially focusing on its Trachealtor device (2021 MDEA gold winner)."],"urls":{"canonical":"https://secwatch.observer/filing/0001663577-23-000139","json":"https://secwatch.observer/filing/0001663577-23-000139.json","markdown":"https://secwatch.observer/filing/0001663577-23-000139.md","text":"https://secwatch.observer/filing/0001663577-23-000139.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1931055/000166357723000139/0001663577-23-000139-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1931055/000166357723000139/mdnc8k033123.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T08:34:33.111613+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}